Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Use of tumor necrosis factor inhibitors in uveitis.

Use of tumor necrosis factor inhibitors in uveitis. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Use of tumor necrosis factor inhibitors in uveitis. Abstract Text:

    c egla rabinovichC Egla Rabinovich,

    PURPOSE OF REVIEW: Use of tumor necrosis factor-alpha blocking agents to treat chronic pediatric uveitis is becoming recognized as an important therapeutic modality. This review summarizes the rationale for this use, highlighting new studies of these agents in pediatric uveitis. RECENT FINDINGS: The majority of patients with pediatric uveitis either have idiopathic uveitis or uveitis associated with juvenile idiopathic arthritis. Ophthalmologic morbidity among these children is common. Most studies evaluating tumor necrosis factor-alpha blockade in pediatric uveitis are retrospective case series, with attendant limitations that are inherent to any retrospective study. Study of uveitis has been hampered by lack of standardization of disease and outcome measures, which has been addressed by uveitis experts with publication of consensus measures. Data to date suggest that tumor necrosis factor-alpha blockade is efficacious in refractory uveitis. Agents with direct tumor necrosis factor-alpha membrane receptor binding activity may be the most efficacious. There remain many unanswered questions in the treatment of pediatric uveitis, including optimal dosing regimen and long-term efficacy. SUMMARY: Tumor necrosis factor-alpha blocking agents play an important role in the treatment of chronic pediatric uveitis. Prospective comparative studies are needed so that we may better understand this role.

    Use of tumor necrosis factor inhibitors in uveitis. Publishing Authors By Initials

    ce rabinovichCE Rabinovich,

    For similar eye diseases: uveal diseases: uveitis research abstracts see: eye diseases: uveal diseases: uveitis research

    PUBMED ID PMID:

    MEDLINE DATE:

    Use of tumor necrosis factor inhibitors in uveitis. Journal Published:

    PUBLICATION TYPE: Review

    Journal: Current opinion in rheumatology

    VOLUME: 19

    Page Numbers: 482-6

    Journal Abbreviation:

    ISSN: 1040-8711

    DAY: 20

    MONTH: Sep

    YEAR: 2007

    Use of tumor necrosis factor inhibitors in uveitis. Information

    Number of References: 31

    LANGUAGE: eng

    NlmUniqueID: 9000851

    Use of tumor necrosis factor inhibitors in uveitis. Keywords Mesh Terms:

    KEYWORDS: Uveitis

    MESH TERMS: drug therapy

    Chemical & Substance for Abstract: Use of tumor necrosis factor inhibitors in uveitis. Information

    Substance Name: Tumor Necrosis Factor-alpha

    Registry Number: 0

    Grant and Affiliation Information for Use of tumor necrosis factor inhibitors in uveitis.

    AFFILIATION: Division of Pediatric Rheumatology, Duke University Medical Center, Durham, North Carolina 27710, USA. rabin001@mc.duke.edu

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Curr Opin Rheumatol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Use of tumor necrosis factor inhibitors in uveitis Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News